YMTX - Yumanity Therapeutics GAAP EPS of -$1.24 revenue of $1.02M May, 12 2022 04:52 PM Yumanity Therapeutics Inc. Yumanity Therapeutics press release (NASDAQ:YMTX): Q1 GAAP EPS of -$1.24. Collaboration revenue of $1.02M. For further details see: Yumanity Therapeutics GAAP EPS of -$1.24, revenue of $1.02M